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Abstract 22 
Exposure to environmental insults generally occurs at low levels, making it 23 
challenging to measure bacterial responses to such interactions. Additionally, 24 
microbial behaviour and phenotype varies in differing bacterial types or growth 25 
phases, likely giving rise to growth- or species-specific responses to environmental 26 
stimuli. The present study applied a spectrochemical tool, infrared (IR) spectral 27 
interrogation coupled with multivariate analysis, to investigate the growth- and 28 
species-specific responses of two bacterial strains, Gram-negative Pseudomonas 29 
fluorescens and Gram-positive Mycobacterium vanbaalenii, to low concentrations of 30 
tetracycline, nanoparticulate silver (AgNP) or mixtures thereof. Results indicate the 31 
tendency for tetracycline-induced biospectral alterations to occur in outer-cellular 32 
components, e.g., phospholipids or proteins, while AgNPs-induced changes are 33 
mainly associated with proteins (~ 964 cm−1, ~ 1485 cm−1, ∼ 1550 cm−1, ∼ 1650 34 
cm−1). The primary altered targets are correlated with bacterial membranes or 35 
outer-cellular components. Furthermore, significant lipid changes at 1705-1750 cm−1 36 
were only present in P. fluorescens cells compared to M. vanbaalenii, owing to 37 
differences in cell wall structure between Gram-positive and -negative bacteria. This 38 
study also found distinct biospectral alterations in non-log phase compared to log 39 
phase, confirming bacterial growth-dependent responses to environmental exposures. 40 
It implies that previous studies on log phase only may underestimate the impacts from 41 
exposures of interest in situ, where bacteria stay in different growth stages. Our work 42 
proves the feasibility of biospectroscopy in determining bacterial responses to 43 
low-level environmental exposures in a fast and efficient manner, revealing sufficient 44 
biochemical information continuously through growth phases. As a nondestructive 45 
approach, biospectroscopy may provide deeper insights into the actual and in situ 46 
interactions between microbes and environmental stimuli, regardless of the exposure 47 
level, growth phase, or bacterial types. 48 
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The impacts of environmental insults on microorganisms have been widely studied. 56 
Antibiotics are a group of antimicrobial agents capable of causing environmental 57 
insults of major concern from both a scientific and public perspective. A significant 58 
number and quantity of antibiotics have been extensively applied in human and 59 
veterinary medicine1. Various means by which these drugs and their metabolites enter 60 
the environment post-excretion have been examined. The most common way by 61 
which antibiotics are discharged is via sewage treatment plants with ultimate release 62 
into surface or groundwater. Previous studies point to >40 different categories of 63 
antibiotics found in groundwater and even drinking water, ranging from nanogram per 64 
liter to microgram per liter1-4. Strikingly, residues of veterinary antibiotics enter the 65 
environment in a much more direct way through application of liquid manure as 66 
fertilizer5, 6. 67 
Additionally, nanoparticles (NPs) may also pose high risks to our living 68 
environment. Nanoparticulate silver (AgNP) is one of the most widely-used NPs, 69 
occurring in analytical pathogen-detecting devices, as antibacterial additives in 70 
commercial products (clothing, food containers, wound dressings, implant coatings, 71 
and refrigerators), and in ultrafiltration membranes for water purification7-9. The 72 
abuse and widespread usage of antibiotics and AgNPs may exacerbate risks of 73 
antimicrobial resistance10. Although many studies have addressed such consequences 74 
in living microorganisms, they usually employ very high-level exposures of 75 
antibiotics and AgNPs in the laboratory, generally 100- or even 1000-fold greater than 76 
exposures in real-world scenarios. Thus, the in-vitro outcome of high-level exposure 77 
in reflecting real-world impacts is always questioned11, 12. 78 
Bacteria play a critical role in geochemical processes and are ubiquitously present 79 
in the environment as a unique group of microorganisms. They can be used 80 
advantageously to study the impacts of environmental exposures, but their 81 
communities are incredibly complicated with regards to composition, functions and 82 
dynamics13-16. Gram staining depending on cell membrane structure, for instance, is 83 
the general classification method for categorizing bacteria into Gram-positive or 84 
-negative groupings. The fundamental difference between these two categories is 85 
membrane structure, i.e., there is only a thin peptidoglycan layer (~2-3 nm) between 86 
the cytoplasmic membrane and the outer membrane of Gram-negative bacteria while 87 
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Gram-positive bacteria exhibit a thick peptidoglycan layer of 30 nm but lack an outer 88 
membrane17. Differing attributes of membrane structure may result in distinct 89 
responsive behaviors towards environmental exposures, for instance towards toxicity 90 
and anti-biocide actions18. Additionally, growth phase is another major concern in 91 
studying bacterial communities. Bacterial growth is typically divided via growth rate, 92 
i.e., lag phase, acceleration phase, exponential phase (log-phase), retardation phase, 93 
stationary phase, and phase of decline. In previous studies, log-phase has been the 94 
most investigated, but this condition is seldom found in the natural environment due 95 
to rarity of optimal growth conditions19. Instead, stationary- to death-phase 96 
representing nutrient depletion circumstances may be more representative20. 97 
To date, a wide range of techniques have been used to assess bacterial responses 98 
to environmental exposures, such as Christensen test-tube method (CTT)21, 22, Congo 99 
red agar method (CRA)23, IcaADB gene detection using polymerase chain reaction 100 
(PCR)24, 25, and pulsed-field gel electrophoresis (PFGE)26, 27. However, these 101 
approaches target specific endpoints and are not feasible for diagnosing bacterial 102 
responses to environmental exposures. CTT and CRA primarily require access to pure 103 
cultures. The others are molecular-based, defining the genotype of a whole 104 
community rather than the individual phenotype or behavior. For instance, 105 
distinguishing the functions or behaviours of individual bacterial cells within a 106 
bacterial biofilm is almost impossible via molecular-based methods, owing to the 107 
enormous diversity of bacterial strains and complexity in community structure. 108 
Additionally, these approaches have to be performed under restrictive laboratory 109 
conditions28-30, making it unachievable to discriminate bacterial phenotypes within 110 
complex bacterial communities in real environmental samples. Therefore, an 111 
increasing need for novel high-throughput approaches is raised, allowing one to 112 
analyze the real environmental microbiota in situ via a non-destructive means. 113 
Biospectroscopy has a long history of application in microbiology since the 114 
1960s31, 32. Attributes of biospectroscopy include non-destructive, non-invasive, 115 
high-throughput and label-free, which provide many advantages for the investigation 116 
of environmental and biochemical dynamic changes in low-level exposure 117 
circumstances. In recent studies, biospectroscopy has proved sensitive to 118 
physiological and morphological alterations resulted from low-level environmental 119 
exposures33-35. Specifically, infrared (IR) spectroscopy exploits the principle that 120 
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biochemical bonds perform some degree of vibrations induced by stretching, bending, 121 
scissoring or twisting after energy absorption at particular wavelengths. The 122 
“biochemical-cell fingerprint” region is located within the mid-IR region, which is the 123 
most information-rich about biochemical structures36. Through assessing derived 124 
spectral peaks or alterations, i.e., bio-fingerprints, the biochemical structure of 125 
interrogated targets can be revealed37-39. Additionally, Raman spectroscopy, as a 126 
complementary method to IR, can provide information on chemical bonds and 127 
composition even under a hydrated environment40, 41. Furthermore, another merit of 128 
biospectroscopy over other techniques is that it allows investigations to be undertaken 129 
in situ in real-time, which can generate continuous biochemical information through 130 
the entire biological processes rather than only obtaining static results from specific 131 
time points. 132 
As a broad-spectrum of antibiotic, tetracycline is effective against both Gram- 133 
positive and -negative bacteria with only a few exceptions42, having a history of 134 
several decades usage in animal feeds and consequently probably more ubiquitous in 135 
the natural environment than other in-house antibiotics (e.g., kanamycin)43. The 136 
present study therefore chose tetracycline as the studied antibiotic, discriminating and 137 
assessing bacterial responses to tetracycline and AgNPs via biospectroscopy coupled 138 
with multivariate analysis. Additionally, recent studies have reported the synergistic 139 
antibacterial effects of antibiotics and metals or NPs44, e.g., amoxicillin and AgNPs 45, 140 
but its effects on bacterial physiology remains unclear. Our work also considered and 141 
interrogated microbial responses to the binary-exposure of tetracycline and AgNPs via 142 
IR spectroscopy. Regarding the real-world scenario, our results distinguished the 143 
distinct biospectral alterations in different bacterial types and growth phases, helping 144 
one to understand the bacterial behaviour post-exposure to low-level antimicrobials. 145 
We aim to demonstrate that biospectroscopy approaches can characterise 146 
physiological features of bacteria and lend profound insights into the relationship 147 
between these and bacterial responses to environmental insults. 148 
 149 
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Materials and methods 150 
Sample preparation 151 
Unless stated otherwise, all the chemicals used in this study were purchased from 152 
Sigma-Aldrich (UK). The AgNPs (catalogue no. 730785, Sigma-Aldrich, UK) have a 153 
10-nm particle size at a stock concentration of 0.02 mg/mL, dissolved in aqueous 154 
buffer with sodium citrate as stabilizer. Two classic soil bacterial strains, 155 
Mycobacterium vanbaalenii PYR-1 (Gram-positive) and Pseudomonas fluorescens 156 
(Gram-negative), were selected owing to their ubiquity and wide distribution in the 157 
soil environment and their well-known physiological behaviour36, 46-48. These two 158 
strains were cultured in Luria-Bertani (LB) broth at 30±2oC with 150 rpm shaking for 159 
24 h. Bacterial growth was measured every 10 min by optical density at 600 nm 160 
(OD600) with a microplate reader (FLUOstar Omega, BMG Labtech, UK). AgNPs, 161 
tetracycline or AgNPs-tetracycline mixture was added into cell suspensions in early 162 
log-phase (OD600=0.6), respectively. To mimic the low-level exposure in natural 163 
environment49-52, the exposure concentration was set as 4 µg/L for AgNPs and 1 µg/L 164 
for tetracycline. One millilitre of bacterial suspension was taken 2, 8 and 24 h 165 
post-exposure, representing log-phase, stationary-phase and death-phase, respectively. 166 
For each sample, bacterial cells were harvested by centrifugation at 4000 relative 167 
centrifugal force (rcf) for 5 min, and the cell pellets were subsequently washed three 168 
times with sterile deionized water and 70% ethanol to fix bacteria and remove 169 
residues of growth media. The fixed samples were then applied onto Low-E slides for 170 
subsequent spectrochemical analysis. 171 
Spectrochemical analysis 172 
IR spectra were acquired via a Bruker TENSOR 27 FTIR spectrometer (Bruker Optics 173 
Ltd., UK) equipped with a Helios ATR attachment containing a diamond internal 174 
reflection element (IRE). Instrument parameters were set at 32 scans and 16 cm−1 175 
resolution. A total number of 30 spectra were acquired per sample through the ATR 176 
magnification-limited viewfinder camera. Before measuring each new specimen, the 177 
crystal was cleaned with deionized water, and background readings were retaken. 178 
Raman spectra were acquired via an InVia Renishaw Raman spectrometer 179 
(Renishaw Inc. Gloucester, Gloucestershire, UK). After calibration, sample slides 180 
were placed on an operating stage (a Renishaw automated 100 nm encoded XYZ 181 
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stage), and a 50× objective (numeral aperture 0.75) was applied to focus on the cell 182 
pellet. The parameters of measurement included: grating scan type (extended); 183 
spectrum range (400 to 1800 cm-1); configuration (Laser, 785 nm edge); grating (1200 184 
l/mm 633/790); exposure time (30 s); accumulations (1); and, laser power (100%). 185 
When all the parameters were set up, a map measurement was used for analyzing each 186 
colony. The spectrometer’s entrance slit of 50 µm combined with a 1200 lines/mm 187 
(~1.0 cm-1 spectral resolution) diffraction grating dispersing Raman signals onto a 188 
master Renishaw Pelletier cooled charge coupled detector (CCD). A white light 189 
camera mounted on the microscope was used to obtain the darkfield images and 190 
visualize locations for spectral acquisition. For each captured picture of a cell pellet, 191 
25 spectra were randomly obtained. 192 
Spectrochemical data processing 193 
All the initial data generated from ATR-FTIR spectroscopy were analyzed using 194 
MATLAB R2011a (TheMathsWorks, Natick, MA, USA) coupled with the IRootLab 195 
toolbox (http://irootlab.googlecode.com)53. The acquired IR spectra were cut to the 196 
biochemical-cell fingerprint region (1800 - 900 cm-1), undertaken rubberband baseline 197 
correction and normalized to Amide I (1650 cm-1). Multivariate analysis of principal 198 
component analysis-linear discriminant analysis (PCA-LDA) was applied to the 199 
pre-processed data to derive ten uncorrelated principal components (PCs) from 200 
acquired spectra, which account for >99% of the total variance and also maximize 201 
inter-class variance whilst minimizing intra-class variance54-56. Cross-calculation was 202 
subsequently performed to mitigate risk resulting from LDA overfitting57. The 203 
PCA-LDA loadings using (n-1) samples (n = number of samples in dataset) was 204 
trained via leave-one-out cross-validation and then calculated the scores of the rest 205 
sample. This process was performed for all scores within the test. To investigate roles 206 
of reactive oxygen species (ROS) in antibiotic action and resistance, the 207 
CySS-to-protein ratio was calculated from derived Raman spectra by dividing the 208 
intensity of cysteine band (CySS, 668 cm-1) by that of protein band (1447 cm−1)34. 209 
Statistical analysis 210 
Statistical significance of differences and variance analysis (P-value <0.05) of 211 
biospectral alterations among different treatments of bacterial types and growth 212 
phases was performed using one-way analysis of variance (ANOVA) with Tukey’s 213 
 9 
post-hoc test. All statistical analyses were carried out in GraphPad Prism 6. 214 
Multivariate regression trees (MRT) were used to analyze the influence of bacterial 215 
type, growth phase and exposure on biospectral alterations using the R package 216 
“mvpart”. Herein, Gram-positive (M. vanbaalenii) and Gram-negative (P. fluorescens) 217 
strains were assigned as 1 and 0. For growth phase, the log-phase, stationary-phase, 218 
and death-phase were assigned as 1, 2 and 3, respectively. The exposure of AgNPs, 219 
tetracycline and their mixtures were assigned as 1, 2 and 3, respectively. 220 
 221 
Results and discussion 222 
Growth curves post-exposure to AgNPs and tetracycline 223 
Growth curves (Figure 1) for M. vanbaalenii (Figure 1A) and P. fluorescens (Figure 224 
1B) show that both strains exhibit approximately a 3 h lag-phase and the log-phase 225 
starts some 3.5 h after initial culture. Both enter the stationary-phase at approximately 226 
11 h (OD600=1.2). After about 30 h culture, significant fluctuations indicate the death 227 
phase stage for both strains. There was no significant difference regarding the growth 228 
between control (non-exposure) and exposure groups (P >0.05). Although previous 229 
work reports a remarkable inhibition of bacterial growth post-exposure to AgNPs58, 230 
the exposure levels herein (4 ng/mL) are much lower than the previous study (10-100 231 
µg/mL) and it therefore appeared not to significantly impact either bacterial strain. 232 
Similarly, low concentrations of tetracycline did not induce any apparent changes on 233 
the respective growth curves either. A previous study reports that Synechocystis sp. 234 
exposure to 1 µg/L of tetracycline for five days exhibited no apparent effect, possibly 235 
because of natural variability in tetracycline resistance59. Additionally, M. vanbaalenii 236 
and P. fluorescens are both environmental bacteria widespread in natural habitats 237 
(water and soil), and they are reported to tolerate insults from low-level exposures of 238 
antimicrobials36. Thus, their growth curves are hardly affected by low-level exposures 239 
to AgNPs or tetracycline. 240 
Growth-dependent spectrochemical alterations derived from IR spectra 241 
Raw spectra reveal very limited information because low-level exposures may only 242 
induce miniscule alterations (Figure 1C and 1D). Multivariate analysis assists in 243 
highlighting the spectral changes and key distinguishing biomarkers representing 244 
 10 
spectral differences. Previous studies indicate that most features align along linear 245 
discriminant one (LD1), which includes most of the spectral information (Figure 2)34, 246 
36. The observed segregation in PCA-LDA scores plots (Figure 2A and 2E) is 247 
significant (P <0.05), indicating distinct biospectral alterations between the growth 248 
phases. The results of one-way ANOVA [see Electronic Supporting Information (ESI) 249 
Table S1 and S2] also demonstrate the statistically significant means of all 250 
segregation categories in each growth phase (P <0.05). 251 
Biospectral discriminant peaks and their tentative assignments illustrate the 252 
interactions between cellular components in different growth stages (Figure 3). The 253 
spectra of M. vanbaalenii show a broad range of variations in stationary-phase 254 
compared to log-phase (Figure 3A), including glycogen (~1018 cm−1), carbohydrate 255 
(~1165 cm−1), symmetric phosphate stretching vibrations (νsPO2-; ~1088 cm−1), COO- 256 
symmetric stretching vibrations of fatty acids and amino acid (~1377 cm−1), lipid 257 
(~1701 cm−1), and proteins (~1474 cm−1)60. The main discriminant peaks in 258 
death-phase include Amide I (∼1650 cm−1), Amide II (∼1550 cm−1), glycogen (~1018 259 
cm−1), and proteins (~1481 cm−1)36, 60. In contrast, the major spectral features of P. 260 
fluorescens are identical in stationary-phase and death-phase (Figure 3E), mainly 261 
comprising proteins and lipids, i.e., Amide I (∼1650 cm−1), Amide II (∼1550 cm−1), 262 
and lipids (1705-1750 cm−1)34, 35. For both strains, the degrees of all the 263 
growth-related alterations illustrate an increasing tendency from stationary-phase to 264 
death-phase, possibly attributed to cellular differentiation under nutrient depleted 265 
conditions in stationary-phase and death-phase, which cause the changing cell wall 266 
structure to adapt to growth circumstances20, 61, 62. The spectral differences between 267 
the two strains is principally contributed by cell membrane structure in that 268 
Gram-negative bacteria contain two lipid-associated bilayers compared to 269 
Gram-positive cells17. The extra membrane in Gram-negative strains (P. fluorescens) 270 
might increase more detectable alterations related to proteins and lipids across growth 271 
phases. 272 
Spectrochemical alterations with AgNPs/tetracycline exposure 273 
Although the exposures herein are low-level, characterizable effects can be identified 274 
post-exposure to AgNPs, tetracycline or their mixtures via biospectrsocopy coupled 275 
with multivariate analysis. The key alterations in M. vanbaalenii post-exposure to 276 
AgNPs include glycogen (~1022 cm−1), proteins (~1485 cm−1), νsPO2- (~1088 cm−1, 277 
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1092 cm−1), carbohydrate (~1165 cm−1), lipids (~1705 cm−1, 1709 cm−1), Amide I 278 
(~1670 cm−1), and protein phosphorylation (~964 cm−1) (Figure 3B)33, 36. Tetracycline 279 
exposure led to discriminating alterations in M. vanbaalenii in Amide III (~1269 280 
cm−1), protein phosphorylation (~964 cm−1), glycogen (~1022 cm−1), Amide I (~1609 281 
cm−1, 1612 cm−1, 1659 cm−1), COO- symmetric stretching vibrations of fatty acids 282 
and amino acid (~1408 cm−1), and lipids (~1701 cm−1, 1713 cm−1)60 (Figure 3C). 283 
However, for P. fluorescens, the biomarkers in both individual treatments are further 284 
concentrated on proteins (∼1650 cm−1, ∼1550 cm−1) and lipids (1705-1750 cm−1)34, 36 285 
(Figure 3F and 3G). 286 
In binary exposure treatments, more complex profile differences in spectral 287 
alterations in ATR-FTIR spectra are observed. The primary changes in M. 288 
vanbaalenii are consistent with proteins (∼1650 cm−1) and lipids (1705-1750 cm−1) in 289 
all growth phases (Figure 3D)34, 36. In contrast, the exposure-associated spectral 290 
alterations in P. fluorescens vary significantly with growth phase (Figure 3H), e.g., 291 
the biomarkers in stationary-phase with binary effects include glycogen (~1053 cm−1), 292 
Amide I (~1609 cm−1), COO- symmetric stretching vibrations of fatty acids and 293 
amino acid (~1389 cm−1), asymmetric phosphate stretching vibrations (νasPO2-; ~ 294 
1196 cm−1), lipid (~ 1732 cm−1), and Amide II (~1508 cm−1)35, 60. They change to 295 
lipid (~1709 cm−1 and 1751 cm−1), Amide I (~1609 cm−1), Amide II (~1543 cm−1), 296 
νasPO2- (~1211 cm−1) and glycogen (~1053 cm−1)36, 60 in death-phase. 297 
In general, most spectral alterations post-exposure are associated with lipids and 298 
proteins indicating bacterial cell membranes are primary targets, probably because 299 
tetracycline or AgNPs penetrate bacterial cells via passive diffusion and inhibits 300 
bacterial growth by disturbing protein synthesis or altering membrane structure63. 301 
Through growth phases, Gram-negative bacteria inhibit a broad range of alterations 302 
associated with lipids, e.g., (1705 − 1750 cm−1), which is absent in Gram-positive 303 
bacteria, mainly attributed to their different cell wall composition. The rigidity and 304 
extended cross-linking may reduce target sites on cell wall for environmental 305 
exposure and increase difficulties in antimicrobial penetration44. 306 
Factors influencing spectrochemical alteration 307 
From conducted spectral analysis, factors inducing IR spectral alterations can be 308 
classified as intrinsic and external categories. The inherent one includes bacterial type 309 
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(Gram-positive or Gram-negative) and growth phase, and the external category refers 310 
to the types of exposure. These factors function and interact simultaneously, with 311 
distinct impacts on microbial responses to environmental exposures. To quantify the 312 
importance of each factor, multivariate regression tree (MRT) analysis was conducted 313 
through the isolated discriminating biomarkers (characteristic peaks). The MRT graph 314 
illustrates the relationship of spectral variations and impact factors with four splits 315 
according to bacterial types, growth phase and exposure groups, explaining 90.8% of 316 
spectral variance (Figure 5). 317 
Spectral variation is first split by bacterial type which accounts for 65.6% of the 318 
total variation, owing to more changes associated with membrane components 319 
observed in P. fluorescens (Gram-negative) than M. vanbaalenii (Gram-positive), e.g., 320 
proteins and phospholipid-derived fatty acids. Multivariate analysis also illustrates 321 
various spectrochemical alterations between P. fluorescens and M. vanbaalenii. For 322 
example, significant lipid changes (1705-1750 cm−1) present in P. fluorescens 323 
treatments are absent in M. vanbaalenii treatments. The cell membrane of 324 
Gram-negative bacteria contains two lipid associated bilayers, which is likely to 325 
increase the influence of applied exposure on the cell wall structure, while there is 326 
only one lipid bilayer in the membrane and a thick ring of peptidoglycan and teichoic 327 
acid of Gram-positive bacteria17. This difference may influence the structural integrity 328 
and eventually the microbial response to external stimuli. Furthermore, both 329 
Gram-positive and -negative bacteria from stationary phase show a comprehensive 330 
range of alterations in cellular components (i.e., Amide I, II, III, νasPO2-/ νsPO2-, 331 
glycogen, carbohydrates, lipids, etc.; Figure 6), indicating many underlying biological 332 
activities. This can be primarily attributed to a growing cell wall from log to 333 
stationary phase, which increases the amounts of membrane components64 and 334 
induces changes on the surface of the bacterial envelope and protein synthesis20. Such 335 
changes may have considerable influence on the rigidity of the cells, resistance to 336 
environmental changes, as well as immunochemical properties. Results of both MRT 337 
and multivariate analyses therefore suggest bacterial type as the primary intrinsic 338 
factor determining IR alterations post-exposure to AgNP or tetracycline. 339 
Growth phase also shows significant impacts on bacterial spectra after 340 
environmental exposure. The Gram-negative group is further split in the MRT graph 341 
by growth phase (i.e., log-phase vs. stationary-phase and death-phase), owing to 342 
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increasing alterations of membrane components along with the growth stage, which 343 
explains 13.2% of total variation (Figure 5). Similarly, multivariate analysis 344 
demonstrates the same growth-dependent results. Post-exposure to AgNP for instance, 345 
the spectra of both strains in log-phase are clearly separated from those in 346 
stationary-phase or death-phase (Figure 2B-D). The induced alterations from growth 347 
phases are associated with various cellular components. Specifically in log-phase, IR 348 
spectral biomarkers reflecting the major alterations of M. vanbaalenii post-exposure 349 
to AgNP are Amide I (~1612 cm-1), COO- symmetric stretching vibrations of fatty 350 
acids and amino acids (~1381 cm-1), lipid (~1717 cm-1), glycogen (~1011 cm-1), 351 
νasPO2- (~1215 cm-1), and carbohydrate (~1165 cm-1) (Figure 6A)36, 60. However, 352 
samples from stationary-phase exhibit a contrasting profile consisting only of 353 
alterations of proteins (~1377 cm-1) and Amide I, II, III (~1609 cm-1, 1566 cm-1, 1254 354 
cm-1) (Figure 6B)33. In tetracycline or tetracycline-AgNP mixture treatments, the 355 
most-induced biomarkers in log-phase shift to proteins, i.e., Amide I (~1163 cm-1, 356 
1616 cm-1), Amide II (~1520 cm-1, 1558 cm-1) and Amide III (~1327 cm-1) (Figure 357 
6A)33, but they are associated more with cellular components in stationary-phase, 358 
including Amide I (~1589 cm-1), Amide II (~1551 cm-1), Amide III (~1269 cm-1; 1273 359 
cm-1), proteins (~1485 cm-1), lipid (~1717 cm-1, 1721 cm-1), COO- symmetric 360 
stretching vibrations of fatty acids and amino acid (~1342 cm-1; 1381 cm-1), νsPO2- 361 
(~1069 cm-1), νasPO2- (~1196 cm-1) and glycogen (~1018 cm-1) (Figure 6B)60. 362 
Samples from death-phase cultures exhibit distinct patterns as compared to log- or 363 
stationary-phase in that AgNP and tetracycline-AgNP mixture show more impacts on 364 
proteins (Figure 6C). These results indicate the changing physiological profiles of 365 
bacterial cells with growth stage, and the different modifications associated with 366 
cellular components with adaptation to the living environment. For instance, bacteria 367 
facing nutrient depletion are reported to produce more hydrophobic molecules to 368 
protect the starved cells, resulting in less fluid and permeable membranes attributed to 369 
the transformations within the fatty acid composition, which increase protection and 370 
insulation from a stressful environment20, 61, 62. Moreover, entering stationary phase, a 371 
wide range of protein synthesis is also altered by the global gene regulatory network, 372 
which tends to swap the core functions from metabolism or catabolism to the 373 
maintenance of cellular viability20, possibly explaining more spectral alterations of 374 
proteins in stationary- and death-phase than log-phase. 375 
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Besides intrinsic factors, external environmental exposure explains 12.0% of total 376 
variation in MRT for Gram-positive (2.7%) and Gram-negative (9.3%) bacteria. For 377 
both strains, segregation mainly results from different spectrochemical alterations 378 
between AgNP exposure and tetracycline/binary groups. The key spectral alterations 379 
in the AgNP category are located at COO- symmetric stretching vibrations of fatty 380 
acids and amino acid (~1373 cm-1), (~1736 cm-1), proteins (~984 cm-1, 988 cm-1), 381 
Amide I (1612 cm-1, 1694), Amide II (1543 cm-1, 1562 cm-1), and νsPO2- (1088 cm-1) 382 
(Figure 3B and 3F)36, 60. In contrast, changes induced by tetracycline or 383 
tetracycline-AgNP mixture are associated with COO- symmetric stretching vibrations 384 
of fatty acids and amino acid (~1373 cm-1), proteins (~984 cm-1), lipids (~1697 cm-1; 385 
1732 cm-1), and Amide I, II (~1562 cm-1, 1616 cm-1) (Figure 3C and 3G)60. 386 
It can be concluded that AgNP-induced spectral changes are mainly associated 387 
with proteins, whereas broader cellular components are affected post-exposure to 388 
tetracycline or tetracycline-AgNP mixture. It might be explained by tetracycline 389 
penetrating cells via passive diffusion, which alters bacterial growth by inhibiting 390 
protein synthesis or destroying the membrane. Phospho-lipids or proteins are 391 
therefore more significantly affected as the primary receptors of passively 392 
accumulated tetracycline63. Although mechanisms of AgNP interacting with 393 
cytoplasmic membranes and penetrating into cells remain unclear58, 65, our data 394 
suggest that AgNP-induced alterations might be derived from some specific active 395 
sites interacting with AgNP, e.g., sulfur-containing proteins following a similar 396 
mechanism as thiol groups of respiratory chain proteins and transport proteins66-68. 397 
To further assess the impact of exposure, the inter-category multivariate distances 398 
of each category were also evaluated. PCA-LDA scores plots that compare the 399 
spectrochemical alterations of the two bacterial strains within the same growth phase 400 
are shown in Figure 4. The results illustrate distinct clustering of tetracycline 401 
exposure away from the control category, but not for AgNP categories, whereas the 402 
binary group is located between AgNP and tetracycline categories. The spectral 403 
differences of M. vanbaalenii between categories of control and binary exposure are 404 
slightly reduced within 0.1 as compared to the tetracycline exposure category, 405 
indicating that AgNP may confer the exposure effect of tetracycline. Similar 406 
alterations are observed for P. fluorescens. Additionally, for both M. vanbaalenii and 407 
P. fluorescens, the AgNP and tetracycline categories in the stationary- or death-phase 408 
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shift in an opposite direction from the control, and the binary exposure category 409 
locates closer to the tetracycline exposure group than control or AgNP exposure. This 410 
finding is supported by a range of identical alterations identified in both AgNP and 411 
binary exposure groups from stationary-phase to death-phase (i.e., lipids, Amide I, II, 412 
III, νasPO2-/ νsPO2-). 413 
Additionally, the analysis of reactive oxygen species (ROS) was also conducted 414 
to evaluate the exposure impacts by calculating the CySS-to-protein ratio, derived 415 
from Raman spectra (Figure 7), which points to cellular ROS levels34. Interestingly, 416 
comparing to control category, only tetracycline-binary exposure appears to increase 417 
ROS level (P <0.05), whereas the induction of AgNP and tetracycline exposure is not 418 
significant. Previous studies report the independent mechanisms of antimicrobials on 419 
the involvement of ROS69, 70. The results herein hint at no ROS generation from 420 
individual AgNP or tetracycline exposure, and the spectrochemical alterations more 421 
likely result from the direct inhibition of cell-wall assembly, protein synthesis and 422 
DNA replication. In binary exposure, AgNP penetration across the cell membrane 423 
might increase permeability and result in more tetracycline entering the bacterial cell, 424 
consequently triggering a ROS response44, 71-74. 425 
Conclusions 426 
The present study demonstrates that spectrochemical techniques coupled with 427 
multivariate analysis are a robust tool for investigating the bacterial response to 428 
environmental exposures, revealing biochemical information longnitudinally at 429 
low-level exposures. This approach can be applied to characterize and assess bacterial 430 
alterations effectively post-exposure to a tetracycline and/or AgNP through growth 431 
phases and is potentially feasible for in situ interrogation of antimicrobial effects in 432 
real-time. Deeper insights into biospectral alterations in non-log phases pertaining 433 
nutrient depletion conditions, which fits better with the real-world scenario of 434 
microcosms, uncovers the distinct changes of biochemical fingerprints across growth 435 
periods, hinting at an underestimation of antimicrobial effects in previous studies. 436 
Bacterial type is ranked as the primary factor affecting microbial response to 437 
environmental stimuli by MRT analysis, followed by growth phase and types of 438 
antimicrobials. These findings will help our better understanding of the real 439 
interactions between microbes and low-level antimicrobials under natural 440 
environmental conditions, e.g., nutrient depletion. 441 
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Figure Cations 603 
Figure 1. Growth curves of M. vanbaalenii (A) and P. fluorescens (B) under AgNP, 604 
tetracycline and AgNP-tetracycline binary exposures. The exposure concentrations 605 
were 4 µg/L for AgNP and 1 µg/L for tetracycline. IR spectral average of M. 606 
vanbaalenii (C) and P. fluorescens (D) in different exposure treatments. The groups 607 
of “Log control”, “Log silver”, “Log tet” and “Log binary” refer to samples collected 608 
at log-phase following treatments of control, silver, tetracycline and binary-exposure, 609 
respectively. 610 
Figure 2. Exposure effects within different growth phases (scale range of Y axis: -0.2 611 
~ 0.2). The Y axis refers to the values of LD1. M. vanbaalenii: control (A), 612 
post-exposure to AgNP (B), post-exposure to tetracycline (C), and post-exposure to 613 
AgNP-tetracycline mixture (D). P. fluorescens: control (E), post-exposure to AgNP 614 
(F), post-exposure to tetracycline (G), and post-exposure to AgNP-tetracycline 615 
mixture (H). 616 
Figure 3. Vector-cluster analysis of exposure effects within different growth phases. 617 
M. vanbaalenii: control (A), post-exposure to AgNP (B), post-exposure to tetracycline 618 
(C), and post-exposure to AgNP-tetracycline mixture (D). P. fluorescens: control (E), 619 
post-exposure to AgNP (F), post-exposure to tetracycline (G), and post-exposure to 620 
AgNP-tetracycline mixture (H). 621 
Figure 4. Exposure effects within the same growth phase. The Y axis refers to the 622 
values of LD1 in range of -0.2 to 0.2. M. vanbaalenii: log-phase (A), stationary-phase 623 
(B), and death-phase (C). P. fluorescens: log-phase (D), stationary-phase (E), and 624 
death-phase (F). 625 
Figure 5. Multivariate regression tree (MRT) analysis of environmental variables 626 
explaining the discriminating biomarkers. The scale of the sub-figures represents the 627 
alteration degree (1.0 refers to the average level). Blue bars for wavelengths 628 
representing proteins, yellow bars for phospholipid-derived fatty acids, and grey bars 629 
for other cellular components. 630 
Figure 6. Vector-cluster analysis of exposure effects within the same growth phase. 631 
M. vanbaalenii: log-phase (A), stationary-phase (B), and death-phase (C). P. 632 
fluorescens: log-phase (D), stationary-phase (E), and death-phase (F). 633 
 24 
Figure 7. Ratio of cysteine (CySS, 668 cm-1) to protein (1447 cm−1) derived from 634 
Raman spectra. Data are presented in mean ± standard error. 635 
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